Literature DB >> 17535186

Botulinum neurotoxin A: an unusual systemic effect.

Katherine Howell1, Paulo Selber, H Kerr Graham, Dinah Reddihough.   

Abstract

Systemic effects from Botulinum neurotoxin A are uncommon but can have serious consequences. We report the case of a boy with severe cerebral palsy who developed deterioration in respiratory and oromotor function following repeated injections of Botulinum neurotoxin A. Caution is needed in using this treatment in children with severe cerebral palsy and pseudobulbar palsy.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17535186     DOI： 10.1111/j.1440-1754.2007.01122.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN： 1034-4810            Impact factor:   1.954


  15 in total

1.  Comment on: "Botulinum Toxin in the Management of Children with Cerebral Palsy".

Authors:  Katherine Langdon; Lisa Copeland; Priya Edwards; Kate Rodwell; Kim McLennan; Theresa Carroll; Sasaka Bandaranayake; Adam Scheinberg; Mary-Clare Waugh; Heather Burnett; Neil Wimalasundera; Sabine Hennel; Eewei Lim; Steve O'Flaherty
Journal:  Paediatr Drugs       Date:  2019-12       Impact factor: 3.022

2.  Growth effects of botulinum toxin type A injected unilaterally into the masseter muscle of developing rats.

Authors:  Chanyoung Park; Kitae Park; Jiyeon Kim
Journal:  J Zhejiang Univ Sci B       Date:  2015-01       Impact factor: 3.066

Review 3.  Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature.

Authors:  Beth E Crowner; Diego Torres-Russotto; Alexandre R Carter; Brad A Racette
Journal:  Clin Neuropharmacol       Date:  2010 Sep-Oct       Impact factor: 1.592

Review 4.  Use of botulinum toxin A in adult neurological disorders: efficacy, tolerability and safety.

Authors:  Wilhelm J Schulte-Mattler
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 5.  Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).

Authors:  Brian J Hoare; Margaret A Wallen; Christine Imms; Elmer Villanueva; Hyam Barry Rawicki; Leeanne Carey
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

6.  Adductor release and chemodenervation in children with cerebral palsy: a pilot study in 16 children.

Authors:  Abhay Khot; Samuel Sloan; Sameer Desai; Adrienne Harvey; Rory Wolfe; H Kerr Graham
Journal:  J Child Orthop       Date:  2008-06-07       Impact factor: 1.548

7.  Evaluation of the effects of botulinum toxin A injections when used to improve ease of care and comfort in children with cerebral palsy whom are non-ambulant: a double blind randomized controlled trial.

Authors:  Megan Thorley; Samantha Donaghey; Priya Edwards; Lisa Copeland; Megan Kentish; Kim McLennan; Jayne Lindsley; Laura Gascoigne-Pees; Leanne Sakzewski; Roslyn N Boyd
Journal:  BMC Pediatr       Date:  2012-08-09       Impact factor: 2.125

8.  Therapeutic use of botulinum toxin in neurorehabilitation.

Authors:  Domenico Intiso
Journal:  J Toxicol       Date:  2011-09-14

Review 9.  Best clinical practice in botulinum toxin treatment for children with cerebral palsy.

Authors:  Walter Strobl; Tim Theologis; Reinald Brunner; Serdar Kocer; Elke Viehweger; Ignacio Pascual-Pascual; Richard Placzek
Journal:  Toxins (Basel)       Date:  2015-05-11       Impact factor: 4.546

10.  Focal treatment of spasticity using botulinum toxin A in cerebral palsy cases of GMFCS level V: evaluation of adverse effects.

Authors:  Ana Paula Tedesco; Juliana Saccol Martins; Renata D'Agostini Nicolini-Panisson
Journal:  Rev Bras Ortop       Date:  2014-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.